Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Cantor Fitzgerald

Tracked across 45 events · 1344 articles · First seen Apr 08, 2025 · Last active Aug 21, 2026

Sentiment
13
Attention
8
Events
45
Relationships
36
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Cantor Fitzgerald announced on August 19, 2026 that it will offer its roughly 3,000 institutional clients access to Kalshi's prediction markets, making it one of the first full-service investment banks to provide institutional block trading…
Impact: Cantor Fitzgerald is the primary initiator, leveraging its institutional client base to expand into prediction markets, positioning itself as a pioneer in bringing Wall Street access to this asset class.
Aug 19, 2026 · 8 articles
4 20
Business
Impact: Cantor Fitzgerald is the sponsor of Vista Equity Partners and its affiliate, Cantor Fitzgerald & Co., acted as the sole book-running manager for the IPO, benefiting from the successful offering.
Jun 16, 2026 · 7 articles
2 40
Business
Impact: Cantor Fitzgerald & Co. served as the sole book-running manager for the IPO, indicating its role in facilitating the offering and benefiting from associated fees.
Jun 25, 2026 · 6 articles
2 10
Business
Impact: Cantor Fitzgerald & Co. is serving as the sole book-running manager for Meridian3 Industrials Acquisition Corp's IPO, overseeing the offering and having an option to purchase additional units.
Apr 20, 2026 · 6 articles
4 10
Business
Impact: Cantor Fitzgerald is acting as a joint bookrunning manager for the public offering by Tango Therapeutics, playing a role in managing the transaction.
Jun 08, 2026 · 8 articles
4 10
Business
Impact: Cantor Fitzgerald is acting as a joint book-running manager for the public offering by IDEAYA Biosciences, contributing to the securities offering.
Jun 08, 2026 · 9 articles
2 10
Business
Impact: Cantor Fitzgerald & Co. is acting as the sole book-running manager for the IPO of BV Investment Partners, facilitating the offering and potentially earning fees.
Jun 04, 2026 · 7 articles
2 10
Business
Impact: Cantor Fitzgerald & Co. is serving as the sole book-running manager for the IPO of Osprey Acquisition Corp. III and has an option to purchase additional units.
Jun 30, 2026 · 6 articles
4 10
Business
Impact: Cantor Fitzgerald is acting as a joint book-running manager for Trevi Therapeutics' public offering.
Apr 16, 2026 · 7 articles
4 10
Business
Impact: Cantor acted as a joint bookrunner for Duos Technologies Group's registered direct offering, assisting in the transaction and receiving underwriting fees.
Jun 17, 2026 · 6 articles
4 0
Business
Impact: Cantor is acting as a joint book-running manager for the public offering by Taysha Gene Therapies.
Jun 24, 2026 · 10 articles
4 20
Business
Impact: Cantor Fitzgerald reiterated its Overweight rating and price target for JFrog, highlighting strong cloud revenue growth.
Jun 08, 2026 · 6 articles
4 10
Business
Impact: Cantor Fitzgerald acted as the sole book-running manager for the initial public offering of FutureCorp Space Acquisition 1, facilitating the offering process.
Jun 04, 2026 · 11 articles
2 50
Business
Impact: Cantor acted as a joint book-running manager, contributing to the IPO's execution and earning underwriting fees.
Jul 31, 2026 · 10 articles
2 60
Business
Impact: Cantor Fitzgerald is a joint book-running manager, involved in the offering and earning fees.
Aug 06, 2026 · 6 articles
4 30
Business
Londian Wason New Energy Tech, a leading global manufacturer of electrolytic copper foil, completed its initial public offering on the New York Stock Exchange under the ticker symbol 'FOIL'. The company priced its upsized offering…
Impact: Acted as lead book-running manager for the IPO, earning underwriting fees and strengthening its capital markets franchise.
Jul 20, 2026 · 32 articles
4 5
Business
Impact: Cantor is acting as a joint bookrunner for the public offering, participating in the distribution efforts for Firefly Aerospace's common stock.
May 26, 2026 · 10 articles
6 0
Regulatory
Impact: Cantor Fitzgerald downgraded ADMA Biologics' stock, citing disappointment with the company's response to the Culper Research report, further contributing to the stock's decline.
Apr 01, 2026 · 301 articles
4 0
Business
Impact: Cantor acted as a bookrunner for the offering.
Apr 06, 2026 · 8 articles
4 5
Business
Impact: Cantor is acting as co-manager for the offerings, assisting Morgan Stanley in the capital raise for PureCycle Technologies.
Jun 10, 2026 · 11 articles
4 20
Business
Impact: Cantor Fitzgerald & Co. acted as the sole book-running manager for the IPO of FutureCorp Space Acquisition 1.
Jun 05, 2026 · 6 articles
3 0
Business
Impact: Cantor Fitzgerald increased its price target for AMD to $700, pointing to a 'generational cycle' in AI semiconductors.
Jul 06, 2026 · 6 articles
2 5
Business
Impact: Cantor Fitzgerald acted as joint book-running manager for the offering, earning underwriting fees.
Jul 14, 2026 · 7 articles
2 20
Business
Impact: Cantor Fitzgerald advised Talos on the build-out, signaling its involvement in the prediction market space, but its role is advisory and not central to the event.
Jul 22, 2026 · 6 articles
2 10
Business
Impact: Cantor Fitzgerald is acting as a joint bookrunning manager for the offering, earning underwriting fees and commissions.
Jul 23, 2026 · 7 articles
3 20
Business
Form factor reported strong Q2 2026 results, with adjusted EPS of $0.82 (beat by $0.21) on revenue of $258.2M (beat by ~$18M), up 31.9% YoY. Q3 guidance also exceeded expectations. The stock surged ~26% on…
Impact: Reiterated Overweight rating and $175 price target on Form factor, supporting positive sentiment.
Jul 06, 2026 · 6 articles
6 -20
Regulatory
Paragon Therapeutics, a biotechnology company developing Deramiocel for Duchenne muscular dystrophy, faced a major regulatory setback. On July 27, 2026, the FDA released briefing documents ahead of an advisory committee meeting, raising concerns about post-hoc…
Impact: Analyst firm that published a negative note on the FDA briefing documents.
Jul 27, 2026 · 293 articles
8 5
Business
Impact: Cantor acted as a joint-book running manager for Quantinuum's IPO.
May 26, 2026 · 76 articles
6 10
Business
Impact: Cantor Fitzgerald is acting as financial and capital markets advisor to Vista Equity Partners and as a co-placement agent for the PIPE.
Jun 26, 2026 · 6 articles
1 5
Business
Impact: Acted as sole book-running manager for the IPO, earning underwriting fees.
Jul 10, 2026 · 8 articles
+ 15 more events View on Dashboard
Culper Research Cantor Fitzgerald
Culper Research Cantor Fitzgerald
ADMA Biologics Cantor Fitzgerald
ADMA Biologics Cantor Fitzgerald
Needham & Company Cantor Fitzgerald
Needham & Company Cantor Fitzgerald
JPMorgan Chase Cantor Fitzgerald
JPMorgan Chase Cantor Fitzgerald
Jefferies Cantor Fitzgerald
Jefferies Cantor Fitzgerald
Glancy Prongay & Murray Cantor Fitzgerald
Glancy Prongay & Murray Cantor Fitzgerald
Nasdaq Cantor Fitzgerald
Nasdaq Cantor Fitzgerald
Nasdaq-100 Cantor Fitzgerald
Nasdaq-100 Cantor Fitzgerald
Samsung Electronics Cantor Fitzgerald
Samsung Electronics Cantor Fitzgerald
Bank of America Cantor Fitzgerald
Bank of America Cantor Fitzgerald
Morgan Stanley Cantor Fitzgerald
Morgan Stanley Cantor Fitzgerald
UBS Cantor Fitzgerald
UBS Cantor Fitzgerald
+ 6 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track Cantor Fitzgerald live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.